{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:58:28Z","timestamp":1785445108354,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04418-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:34:07Z","timestamp":1781854447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR17 Suppresses Triple-Negative Breast Cancer Progression and Serves as an Independent Prognostic Biomarke"],"prefix":"10.1186","volume":"24","author":[{"given":"Guannan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"2","key":"4418_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccell.2025.01.002","volume":"43","author":"C Denkert","year":"2025","unstructured":"Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marm\u00e9 F, et al. Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping. Cancer Cell. 2025;43(2):232\u2013. \u2013\u200947.e4.","journal-title":"Cancer Cell"},{"key":"4418_CR2","doi-asserted-by":"publisher","first-page":"1559200","DOI":"10.3389\/fimmu.2025.1559200","volume":"16","author":"Z Ye","year":"2025","unstructured":"Ye Z, Yuan J, Hong D, Xu P, Liu W. Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer. Front Immunol. 2025;16:1559200.","journal-title":"Front Immunol"},{"issue":"1","key":"4418_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12859-024-05749-y","volume":"25","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zeng P, Zhong C. Classifying breast cancer subtypes on multi-omics data via sparse canonical correlation analysis and deep learning. BMC Bioinformatics. 2024;25(1):132.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4418_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41698-025-01062-w","volume":"9","author":"J Karam","year":"2025","unstructured":"Karam J, Rejto PA, Bienkowska JR, Mu XJ, Roh W. Identification of breast cancer subtypes and drug response prediction through forward and reverse translation. NPJ precision Oncol. 2025;9(1):267.","journal-title":"NPJ precision Oncol"},{"issue":"1","key":"4418_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41571-025-01093-z","volume":"23","author":"D Killock","year":"2026","unstructured":"Killock D. Frontline sacituzumab govitecan prolongs PFS in TNBC. Nat reviews Clin Oncol. 2026;23(1):2.","journal-title":"Nat reviews Clin Oncol"},{"issue":"1","key":"4418_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, et al. Advances in immunotherapy for triple-negative breast cancer. Mol Cancer. 2023;22(1):145.","journal-title":"Mol Cancer"},{"key":"4418_CR7","first-page":"265","volume":"17","author":"H Jie","year":"2025","unstructured":"Jie H, Ma W, Huang C. Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review. Breast cancer (Dove Med Press). 2025;17:265\u201374.","journal-title":"Breast cancer (Dove Med Press)"},{"issue":"6","key":"4418_CR8","first-page":"3617","volume":"39","author":"A Turkel","year":"2025","unstructured":"Turkel A, Baydar E, \u00c7olak R, \u00d6zt\u00fcrk AE, \u015eakalar T, Akba\u015f S, et al. The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer. In vivo (Athens. Greece). 2025;39(6):3617\u201325.","journal-title":"Greece)"},{"key":"4418_CR9","doi-asserted-by":"crossref","unstructured":"Luo Y, Tian W, Zhu X, Wei W, Ye F, Situ MY, et al. piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer. Mol Cancer. 2026;25(1):52.","DOI":"10.1186\/s12943-026-02568-y"},{"key":"4418_CR10","doi-asserted-by":"publisher","first-page":"218192","DOI":"10.1016\/j.canlet.2025.218192","volume":"639","author":"F Duan","year":"2026","unstructured":"Duan F, Zhang C, Wu Z, Zhuang L, Zou Y, Wang X, et al. Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation. Cancer Lett. 2026;639:218192.","journal-title":"Cancer Lett"},{"key":"4418_CR11","first-page":"0854","volume":"8","author":"J Zhang","year":"2025","unstructured":"Zhang J, Huang Z, Song C, Wu S, Xie J, Zou Y, et al. PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer. Res (Washington DC). 2025;8:0854.","journal-title":"Res (Washington DC)"},{"key":"4418_CR12","doi-asserted-by":"crossref","unstructured":"Molczyk C, Singh RK. CXCR1: a cancer stem cell marker and therapeutic target in solid tumors. Biomedicines. 2023;11(2):576.","DOI":"10.3390\/biomedicines11020576"},{"issue":"6","key":"4418_CR13","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.gendis.2023.101185","volume":"11","author":"D Wu","year":"2024","unstructured":"Wu D, Chen S, Liu Y, Yang B, Li R, Jin F, et al. Single-cell analyses revealed key tumor-infiltrating myeloid cell subsets associated with clinical outcomes in different subtypes of breast cancer. Genes Dis. 2024;11(6):101185.","journal-title":"Genes Dis"},{"key":"4418_CR14","doi-asserted-by":"crossref","unstructured":"Zhu J, Min N, Gong W, Chen Y, Li X. Identification of hub genes and biological mechanisms associated with non-alcoholic fatty liver disease and triple-negative breast cancer. Life (Basel Switzerland). 2023;13(4):998.","DOI":"10.3390\/life13040998"},{"key":"4418_CR15","doi-asserted-by":"crossref","unstructured":"Jung HH, Kim JY, Cho EY, Lee JE, Kim SW, Nam SJ, et al. A retrospective exploratory analysis for serum extracellular vesicles reveals APRIL (TNFSF13), CXCL13, and VEGF-A as prognostic biomarkers for neoadjuvant chemotherapy in triple-negative breast cancer. Int J Mol Sci. 2023;24(21):15576.","DOI":"10.3390\/ijms242115576"},{"issue":"21","key":"4418_CR16","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-11-1523","volume":"71","author":"Q Li","year":"2011","unstructured":"Li Q, Shi L, Gui B, Yu W, Wang J, Zhang D, et al. Binding of the JmjC demethylase JARID1B to LSD1\/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 2011;71(21):6899\u2013908.","journal-title":"Cancer Res"},{"key":"4418_CR17","doi-asserted-by":"publisher","first-page":"811585","DOI":"10.3389\/fcell.2021.811585","volume":"9","author":"S Zhang","year":"2021","unstructured":"Zhang S, Jiang H, Gao B, Yang W, Wang G. Identification of Diagnostic Markers for Breast Cancer Based on Differential Gene Expression and Pathway Network. Front cell Dev biology. 2021;9:811585.","journal-title":"Front cell Dev biology"},{"issue":"6","key":"4418_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41419-021-03897-0","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Xing R, Ou Z, Zhao J, Hong G, Zhao TJ, et al. G-protein-coupled receptor GPR17 inhibits glioma development by increasing polycomb repressive complex 1-mediated ROS production. Cell Death Dis. 2021;12(6):610.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4418_CR19","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1002\/mco2.159","volume":"3","author":"F Ye","year":"2022","unstructured":"Ye F, Wong TS, Chen G, Zhang Z, Zhang B, Gan S, et al. Cryo-EM structure of G-protein-coupled receptor GPR17 in complex with inhibitory G protein. MedComm. 2022;3(4):e159.","journal-title":"MedComm"},{"issue":"7","key":"4418_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tips.2025.05.001","volume":"46","author":"M Lewash","year":"2025","unstructured":"Lewash M, Kostenis E, M\u00fcller CE. GPR17 - orphan G protein-coupled receptor with therapeutic potential. Trends Pharmacol Sci. 2025;46(7):610\u201328.","journal-title":"Trends Pharmacol Sci"},{"key":"4418_CR21","doi-asserted-by":"crossref","unstructured":"Korbecki J, R\u0119bacz-Maron E, Kupnicka P, Chlubek D, Baranowska-Bosiacka I. Synthesis and significance of arachidonic acid, a substrate for cyclooxygenases, lipoxygenases, and cytochrome P450 pathways in the tumorigenesis of glioblastoma multiforme, including a pan-cancer comparative analysis. Cancers. 2023;15(3):964.","DOI":"10.3390\/cancers15030946"},{"key":"4418_CR22","doi-asserted-by":"crossref","unstructured":"Doan P, Nguyen P, Murugesan A, Subramanian K, Konda Mani S, Kalimuthu V, et al. Targeting orphan g protein-coupled receptor 17 with T0 ligand impairs glioblastoma growth. Cancers. 2021;13(15):3773.","DOI":"10.3390\/cancers13153773"},{"issue":"8","key":"4418_CR23","doi-asserted-by":"publisher","first-page":"e70295","DOI":"10.1002\/mco2.70295","volume":"6","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K\/AKT\/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm. 2025;6(8):e70295.","journal-title":"MedComm"},{"key":"4418_CR24","doi-asserted-by":"crossref","unstructured":"Lappano R, Jacquot Y, Maggiolini M. GPCR modulation in breast cancer. Int J Mol Sci. 2018;19(12):3840.","DOI":"10.3390\/ijms19123840"},{"key":"4418_CR25","doi-asserted-by":"publisher","first-page":"113930","DOI":"10.1016\/j.intimp.2024.113930","volume":"147","author":"C Wang","year":"2025","unstructured":"Wang C, Liu Y, Zhang R, Gong H, Jiang X, Xia S. Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer. Int Immunopharmacol. 2025;147:113930.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4418_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12974-023-02958-9","volume":"20","author":"Y Liang","year":"2023","unstructured":"Liang Y, Kang X, Zhang H, Xu H, Wu X. Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice. J Neuroinflamm. 2023;20(1):271.","journal-title":"J Neuroinflamm"},{"issue":"5","key":"4418_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.neuron.2020.09.016","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang J, He X, Meng H, Li Y, Dmitriev P, Tian F, et al. Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia. Neuron. 2020;108(5):876\u2013e864.","journal-title":"Neuron"},{"key":"4418_CR28","doi-asserted-by":"publisher","first-page":"1482726","DOI":"10.3389\/fmed.2024.1482726","volume":"11","author":"S Ke","year":"2024","unstructured":"Ke S, Huang Y, Wang D, Jiang Q, Luo Z, Li B, et al. BreCML: identifying breast cancer cell state in scRNA-seq via machine learning. Front Med. 2024;11:1482726.","journal-title":"Front Med"},{"key":"4418_CR29","doi-asserted-by":"publisher","first-page":"1479225","DOI":"10.3389\/fonc.2025.1479225","volume":"15","author":"Y Shen","year":"2025","unstructured":"Shen Y, Li C, Tang MY, Huang ZY. Simulation approach for common female cancers: a brief review. Front Oncol. 2025;15:1479225.","journal-title":"Front Oncol"},{"key":"4418_CR30","first-page":"303","volume":"7","author":"IA Voutsadakis","year":"2015","unstructured":"Voutsadakis IA. The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer. Breast cancer (Dove Med Press). 2015;7:303\u201319.","journal-title":"Breast cancer (Dove Med Press)"},{"key":"4418_CR31","doi-asserted-by":"crossref","unstructured":"Bourque K, Jones-Tabah J, Mnasri N, Martin RD, H\u00e9bert TE. Combining optical approaches with human inducible pluripotent stem cells in G protein-coupled receptor drug screening and development. Biomolecules. 2018;8(4):180.","DOI":"10.3390\/biom8040180"},{"key":"4418_CR32","doi-asserted-by":"publisher","first-page":"106870","DOI":"10.1016\/j.intimp.2020.106870","volume":"88","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhou W, Zheng G, Yang G. Inhibition of GPR17 with pranlukast protects against TNF-\u03b1-induced loss of type II collagen in ATDC5 cells. Int Immunopharmacol. 2020;88:106870.","journal-title":"Int Immunopharmacol"},{"key":"4418_CR33","doi-asserted-by":"crossref","unstructured":"Dziedzic A, Miller E, Saluk-Bijak J, Bijak M. The GPR17 Receptor-A promising goal for therapy and a potential marker of the neurodegenerative process in multiple sclerosis. Int J Mol Sci. 2020;21(5):1852.","DOI":"10.3390\/ijms21051852"},{"issue":"40","key":"4418_CR34","doi-asserted-by":"publisher","first-page":"46238","DOI":"10.1021\/acsomega.5c04079","volume":"10","author":"R Satyanarayana","year":"2025","unstructured":"Satyanarayana R, Chaitanya SS, Suresh Kumar I, Thiyagarajan R, Chandrabose S, Abass KS, et al. GPR17 in Glioblastoma: Structure, Ligand Interactions, and Therapeutic Targeting. ACS omega. 2025;10(40):46238\u201347.","journal-title":"ACS omega"},{"key":"4418_CR35","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang H, Wang C, Jiang A, Zhao F, Yang S, et al. ZBTB7B inhibits glioma tumorigenicity by upregulating GPR17 and CXCL10. J Mol Cell Biol. 2026;17(11):mjaf043.","DOI":"10.1093\/jmcb\/mjaf043"},{"issue":"1","key":"4418_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350.","journal-title":"Lancet Oncol"},{"issue":"23","key":"4418_CR37","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/cmdc.201600453","volume":"11","author":"G Marucci","year":"2016","unstructured":"Marucci G, Dal Ben D, Lambertucci C, Santinelli C, Spinaci A, Thomas A, et al. The G\u2005Protein-Coupled Receptor GPR17: Overview and Update. ChemMedChem. 2016;11(23):2567\u201374.","journal-title":"ChemMedChem"},{"issue":"6","key":"4418_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cellsig.2016.03.001","volume":"28","author":"C Parravicini","year":"2016","unstructured":"Parravicini C, Daniele S, Palazzolo L, Trincavelli ML, Martini C, Zaratin P, et al. A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights. Cell Signal. 2016;28(6):631\u201342.","journal-title":"Cell Signal"},{"key":"4418_CR39","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3389\/fonc.2020.01672","volume":"10","author":"D Cancilla","year":"2020","unstructured":"Cancilla D, Rettig MP, DiPersio JF. Targeting CXCR4 in AML and ALL. Front Oncol. 2020;10:1672.","journal-title":"Front Oncol"},{"issue":"2","key":"4418_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12975-023-01201-0","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Jiang A, Yan J, Wen D, Gu N, Li Z, et al. Inhibition of GPR17\/ID2 Axis Improve Remyelination and Cognitive Recovery after SAH by Mediating OPC Differentiation in Rat Model. Translational stroke Res. 2025;16(2):178\u201393.","journal-title":"Translational stroke Res"},{"issue":"6","key":"4418_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3892\/ol.2022.13293","volume":"23","author":"Y Yokoyama","year":"2022","unstructured":"Yokoyama Y, Iioka H, Horii A, Kondo E. Crumbs3 is expressed in oral squamous cell carcinomas and promotes cell migration and proliferation by affecting RhoA activity. Oncol Lett. 2022;23(6):173.","journal-title":"Oncol Lett"},{"issue":"6","key":"4418_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJ Stork","year":"2002","unstructured":"Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12(6):258\u201366.","journal-title":"Trends Cell Biol"},{"key":"4418_CR43","doi-asserted-by":"crossref","unstructured":"Hu Y, Luo H, Zhu X, Guo H. CRNDE\/ETS1\/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma. Comput Math Methods Med. 2021;2021:7566365.","DOI":"10.1155\/2021\/7566365"},{"key":"4418_CR44","doi-asserted-by":"publisher","first-page":"106315","DOI":"10.1016\/j.nbd.2023.106315","volume":"187","author":"M Boccazzi","year":"2023","unstructured":"Boccazzi M, Macchiarulo G, Lebon S, Janowska J, Le Charpentier T, Faivre V, et al. G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation. Neurobiol Dis. 2023;187:106315.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"4418_CR45","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/glia.22896","volume":"63","author":"M Fumagalli","year":"2015","unstructured":"Fumagalli M, Bonfanti E, Daniele S, Zappelli E, Lecca D, Martini C, et al. The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization. Glia. 2015;63(12):2327\u201339.","journal-title":"Glia"},{"key":"4418_CR46","doi-asserted-by":"crossref","unstructured":"Liu Y, Huang C, Luo M, Lu W, Zhang B, Bai L et al. C1q(+) Macrophage-Tumor Cell Interaction Promoted Tumorigenesis via GPR17\/PI3K\/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2025;12(26):e2503434.","DOI":"10.1002\/advs.202503434"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04418-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04418-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04418-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:03:48Z","timestamp":1785441828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04418-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4418"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04418-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Affiliated Hospital of Panzhihua University (approval number: 2020023) before the study began. Written informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"316"}}